Search Results
Dr Facon on the Implications of Isatuximab Plus VRd in Transplant-Ineligible Newly Diagnosed Myeloma
Isatuximab + Len/Dex/Bortezomib vs IsaRd in Newly Diagnosed Transplant Ineligible Multiple Myeloma
Myeloma: Frontline Therapy for Transplant Ineligible Patients
What are new treatment options for newly-diagnosed multiple myeloma patients? Dr. Paul G. Richardson
IMF Patient & Family Webinar - Back to Basics: From Testing to Tailored Therapy
Hematology Round Up #EHA24
Treating Transplant-Ineligible Multiple Myeloma
An Overview of Myeloma for Patients Who Are Just Getting Started: Presented by Dr. Joseph Mikhael
IMF Virtual Regional Community Workshop (RCW) - New England
CMRG 2022 Review of the 64th ASH Annual Meeting and Exposition
First-Line or Frontline Therapy Options In Multiple Myeloma | 2023 IMF Patient and Family Seminar
IMWG Conference Series: Making Sense of Treatment ASH 2024
